| Cyprus | “Cyprus Rheumatology Society: Position statement on the use of biosimilars in rheumatic diseases” http://www.rheumatism.org.cy/userfiles/FINAL%20Rheuma%20Position%20Statement_GREEK.28-08-.pdf |
| Portugal | “The Portuguese Society of Rheumatology position paper on the use of biosimilars” http://www.ncbi.nlm.nih.gov/pubmed/24811463 |
| Spain | “Documento de posicionamiento de la Sociedad Española de Reumatología (SER) sobre famacos biosimilars” http://www.ser.es/actualidad/noticias/documento-de-posicionamiento-de-la-ser-sobre-farmacos-biosimialres/1842 Available in Spanish and English |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.